Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2017; 38(04): 427-429
DOI: 10.4103/ijmpo.ijmpo_113_16
Original Article

Rational Use of Imaging to Stage Breast Cancer: Evidences for a Selective Approach

S G D Gangadaran
Department of Medical Oncology, Government Royapettah Hospital, Chennai, Tamil Nadu, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Introduction: Staging investigations at diagnosis are customary to accurately assign a clinical stage before therapy. The practice of routine imaging in patients asymptomatic for metastasis is not recommended but widely adopted. This study was done to reexamine the basis behind guideline recommendations and to identify the factors predictive of asymptomatic metastasis. Methods: Oncology records of 200 breast cancer patients in clinical Stages I-III at diagnosis were prospectively reviewed. Baseline demographic information, tumor characteristics, and pathological data including molecular typing were collected. The prevalence of metastasis deduced and accuracy of bone scan, chest X-ray (CXR), liver ultrasound, andcomputed tomography (CT) chest analyzed. Patient and tumor characteristics predictive of asymptomatic metastasis tested for significance using appropriate statistical tests. Results: The prevalence of asymptomatic metastasis was 13.5%. Bone lesions (8%) were the mostcommon metastatic site followed by lungs (7%) and liver (1%). Sensitivity, specificity, positive- and negative-predictive values of bone scans and CT chest were 100%, 97%, 74%, 100%, and 92%, 99%, 87, 3%, 99.4%, respectively. The above values for ultrasound abdomen and CXRs were 100%, 99%, 93%, 100% and 21%, 94%, 20%, 94%, respectively. Tumor size (P = 0.001), tumor Stage T1/T2 versus T3/T4 (P = 0.0002), nodal stages N0/N1 versus N2/N3 (P = 0.001), high histological Grade G I versus GII/GIII (P = 0.0001) and molecular types were strongly predictive of metastatic disease. Conclusion: The routine use of imaging to detect distant metastasis in asymptomatic patients is not recommended in newly diagnosed breast cancer. A selective approach may be adopted in individuals with tumor more than 5 cm, advanced nodal disease, higher histological grade, and aggressive molecular types.

Keywords

Baseline investigations - breast cancer - staging imaging - symptomatic metastasis


Publication History

Article published online:
04 July 2021

© 2017. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used forcommercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Myers RE, Johnston M, Pritchard K, Levine M, Oliver T, Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative, et al. Baseline staging tests in primary breast cancer: A practice guideline. CMAJ 2001;164:1439-44.
  • 2 Available from: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13866. [Last accessed on 2015 Nov 26].
  • 3 Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26 Suppl 5:v8-30.
  • 4 Simos D, Catley C, van Walraven C, Arnaout A, Booth CM, McInnes M, et al. Imaging for distant metastases in women with early-stage breast cancer: A population-based cohort study. CMAJ 2015;187:E387-97.
  • 5 Watson RA, Tang DB. The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer. N Engl J Med 1980;303:497-9.
  • 6 Puglisi F, Follador A, Minisini AM, Cardellino GG, Russo S, Andreetta C, et al. Baseline staging tests after a new diagnosis of breast cancer: Further evidence of their limited indications. Ann Oncol 2005;16:263-6.
  • 7 Samant R, Ganguly P. Staging investigations in patients with breast cancer: The role of bone scans and liver imaging. Arch Surg 1999;134:551-3.
  • 8 Chen X, Sun L, Cong Y, Zhang T, Lin Q, Meng Q, et al. Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer. J Exp Clin Cancer Res 2014;33:28.
  • 9 Chen EA, Carlson GA, Coughlin BF, Reed WP Jr., Garb JL, Frank JL, et al. Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer. J Clin Oncol 2000;18:3503-6.
  • 10 Barrett T, Bowden DJ, Greenberg DC, Brown CH, Wishart GC, Britton PD, et al. Radiological staging in breast cancer: Which asymptomatic patients to image and how. Br J Cancer 2009;101:1522-8.
  • 11 Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.